Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland R Griffiths

Showing results (51-60 of 136) with videos related to

Pageof 14
Sort By:
The American Journal of Psychiatry|December 7, 2005
Caffeine dependence in combination with a family history of alcoholism as a predictor of continued use of caffeine during pregnancyDace S Svikis, Nathan Berger, Nancy A Haug, et al.
Journal of Psychopharmacology (Oxford, England)|November 1, 2022
Belief changes associated with psychedelic useSandeep M Nayak, Manvir Singh, David B Yaden, et al.
Current Psychiatry Reports|November 14, 2022
Psychedelic-Assisted Therapy for People with Eating DisordersNatalie Gukasyan, Colleen C Schreyer, Roland R Griffiths, et al.
Journal of Psychoactive Drugs|February 4, 2021
Trends in the Top-Cited Articles on Classic PsychedelicsDavid Wyndham Lawrence, Bhanu Sharma, Roland R Griffiths, et al.
European Journal of Pharmacology|September 1, 2005
Comparison of the behavioral effects of bretazenil and flumazenil in triazolam-dependent and non-dependent baboonsElise M Weerts, Nancy A Ator, Barbara J Kaminski, et al.
Psychopharmacology|September 10, 2014
Inhaled vs. oral alprazolam: subjective, behavioral and cognitive effects, and modestly increased abuse potentialChad J Reissig, Joseph A Harrison, Lawrence P Carter, et al.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|February 29, 2012
Characterization of individuals seeking treatment for caffeine dependenceLaura M Juliano, Daniel P Evatt, Brian D Richards, et al.
Journal of Psychopharmacology (Oxford, England)|September 13, 2014
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addictionMatthew W Johnson, Albert Garcia-Romeu, Mary P Cosimano, et al.
Pharmacology & Therapeutics|December 7, 2018
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network functionMatthew W Johnson, Peter S Hendricks, Frederick S Barrett, et al.
Psychopharmacology|September 9, 2015
Nicotine reinforcement in never-smokersAngela N Duke, Matthew W Johnson, Chad J Reissig, et al.
Pageof 14

Showing results (51-60 of 136) with videos related to

Sort By:
Pageof 14
The American Journal of Psychiatry|December 7, 2005
Caffeine dependence in combination with a family history of alcoholism as a predictor of continued use of caffeine during pregnancyDace S Svikis, Nathan Berger, Nancy A Haug, et al.
Journal of Psychopharmacology (Oxford, England)|November 1, 2022
Belief changes associated with psychedelic useSandeep M Nayak, Manvir Singh, David B Yaden, et al.
Current Psychiatry Reports|November 14, 2022
Psychedelic-Assisted Therapy for People with Eating DisordersNatalie Gukasyan, Colleen C Schreyer, Roland R Griffiths, et al.
Journal of Psychoactive Drugs|February 4, 2021
Trends in the Top-Cited Articles on Classic PsychedelicsDavid Wyndham Lawrence, Bhanu Sharma, Roland R Griffiths, et al.
European Journal of Pharmacology|September 1, 2005
Comparison of the behavioral effects of bretazenil and flumazenil in triazolam-dependent and non-dependent baboonsElise M Weerts, Nancy A Ator, Barbara J Kaminski, et al.
Psychopharmacology|September 10, 2014
Inhaled vs. oral alprazolam: subjective, behavioral and cognitive effects, and modestly increased abuse potentialChad J Reissig, Joseph A Harrison, Lawrence P Carter, et al.
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|February 29, 2012
Characterization of individuals seeking treatment for caffeine dependenceLaura M Juliano, Daniel P Evatt, Brian D Richards, et al.
Journal of Psychopharmacology (Oxford, England)|September 13, 2014
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addictionMatthew W Johnson, Albert Garcia-Romeu, Mary P Cosimano, et al.
Pharmacology & Therapeutics|December 7, 2018
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network functionMatthew W Johnson, Peter S Hendricks, Frederick S Barrett, et al.
Psychopharmacology|September 9, 2015
Nicotine reinforcement in never-smokersAngela N Duke, Matthew W Johnson, Chad J Reissig, et al.
Pageof 14